MarketCapExport financials
AMERISAFE (AMSF)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
AMERISAFE Financial Ratios 2025-2008 | AMSF
Brief overview of AMERISAFE's market valuation
Ratios are assessed across five available annual reports in the 2020–2024 interval.
The latest available valuation ratios are P/E 17.61x (median 15.68x), P/B 3.79x (median 3.29x), P/CF 40.35x (median 32.63x). The combined multiple level is about 15.5% above the company's historical norm, leaving less valuation cushion.
Current earnings relative to valuation equal about 5.7% on the 1/P/E measure. This is a valuation reference, not an expected payout.
The latest available business-quality ratios are ROE 21.5%, ROA 4.8%. Current resource returns are convincing and help explain a higher market valuation.
Price, earnings and growth produce a PEG of 0.49x. A value below one indicates moderate pricing relative to expected growth.
High leverage is part of the financial-sector model, so valuation should be linked to capital, asset quality and ROE.
Overall assessment
AMERISAFE's high quality ratios explain part of the market premium but increase sensitivity to slower growth.
Annual Financial Ratios AMERISAFE
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
19.2 | 17.6 | 15.7 | 18.8 | 15.4 | 11.5 | 14.2 | 16.0 | 25.3 | 15.6 | 13.7 | 14.1 | 17.6 | 17.7 | 18.4 | 8.9 | 6.9 | - |
P/S |
2.8 | 3.2 | 3.2 | 3.5 | 3.2 | 2.9 | 3.6 | 3.0 | 3.1 | 3.1 | 2.4 | 1.9 | 2.2 | 1.6 | 1.6 | 1.2 | 1.2 | - |
EPS |
2.5 | 2.9 | 3.2 | 2.9 | 3.4 | 4.5 | 4.8 | 3.7 | 2.4 | 4.1 | 3.7 | 2.9 | 2.4 | 1.6 | 1.3 | 1.9 | 2.3 | - |
EV (Enterprise Value) |
1.72 B | 1.83 B | 1.87 B | 1.93 B | 1.95 B | 1.97 B | 2.34 B | 2.21 B | 2.21 B | 2.22 B | 1.94 B | 1.68 B | 1.56 B | 1.27 B | 1.2 B | 1.03 B | 267 M | -95.2 M |
EBITDA per Share |
0.04 | 0.06 | 0.07 | 0.07 | 0.05 | 0.05 | - | - | - | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
2319.4 | 1676.5 | 1311.7 | 1476.9 | 1905.6 | 9.4 | - | - | - | - | - | - | - | - | - | - | - | - |
PEG |
-12.6 | - | - | - | - | -1.81 | 0.49 | 0.29 | -0.62 | 1.61 | 0.47 | 0.66 | 0.38 | 0.78 | -0.7 | - | - | - |
P/B |
3.6 | 3.8 | 3.3 | 3.3 | 2.5 | 2.3 | 3.1 | 2.8 | 2.7 | 2.7 | 2.1 | 1.7 | 1.8 | 1.4 | 1.3 | 0.9 | - | - |
P/CF |
81.7 | 40.3 | 32.6 | 37.0 | 26.7 | 15.7 | 16.9 | 11.8 | 9.0 | 10.8 | 10.5 | 5.4 | 6.0 | 6.5 | 10.4 | 6.9 | 12.1 | - |
ROE % |
18.72 | 21.53 | 21.23 | 17.52 | 16.47 | 19.74 | 21.55 | 17.48 | 10.87 | 17.07 | 15.52 | 12.01 | 10.47 | 7.70 | 6.88 | 10.50 | 15.54 | - |
ROA % |
4.17 | 4.78 | 5.05 | 4.38 | 4.69 | 5.89 | 6.21 | 4.73 | 3.05 | 5.13 | 4.69 | 3.68 | 3.28 | 2.40 | 2.10 | 3.09 | - | - |
Current Ratio |
1.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.4 | - | - | - | - | - | - | - | 0.4 | 0.3 | 1.4 | - | - |
DSO |
- | - | - | - | - | - | 259.8 | 275.1 | 269.2 | 255.8 | 261.9 | 250.7 | 264.4 | 288.2 | 170.0 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios AMERISAFE
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.79 | 0.43 | - | 0.73 | 0.73 | 0.47 | - | 0.75 | 0.58 | 0.89 | - | 0.52 | 0.82 | 0.91 | - | 0.59 | 0.32 | 0.9 | - | 0.99 | 1.23 | 1 | 1.48 | 1.21 | 1.24 | 0.56 | 1.77 | 1.11 | 0.93 | 1.01 | 0.98 | 1.03 | 0.88 | 0.84 | 0.03 | 0.86 | 0.81 | 0.71 | 1 | 0.94 | 0.87 | 1.27 | 1.21 | 0.95 | 0.76 | 0.8 | 0.9 | 0.72 | 0.69 | 0.57 | 0.94 | 0.53 | 0.42 | 0.48 | 0.51 | 0.39 | 0.19 | 0.53 | 0.45 | 0.27 | 0.25 | 0.36 |
EBITDA per Share |
0.02 | 0.01 | - | 0.03 | - | 0.01 | - | - | - | 0.02 | - | - | - | 0.02 | - | 0.05 | - | 0.02 | - | 0.04 | - | 0.01 | - | 0.04 | 0.03 | 0.01 | - | 0.04 | 0.02 | 0.01 | - | 0.04 | 0.03 | 0.01 | - | 0.04 | 0.03 | 0.01 | - | 0.05 | 0.03 | 0.02 | - | 0.05 | 0.04 | 0.02 | - | 0.05 | 0.03 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
19.42 | 17.02 | 13.71 | 18.27 | 16.89 | 17.26 | 13.83 | 16.80 | 16.83 | 18.38 | 12.76 | 15.81 | 14.44 | 14.23 | 9.02 | 13.01 | 15.04 | 17.76 | 13.37 | 19.87 | 21.21 | 21.59 | 19.74 | 21.15 | 20.80 | 19.50 | 21.55 | 18.23 | 18.07 | 18.04 | 17.48 | 13.04 | 12.13 | 11.63 | 10.87 | 14.90 | 14.92 | 14.93 | 17.07 | 17.97 | 18.00 | 17.51 | 15.52 | 14.21 | 13.28 | 12.98 | 12.01 | 12.42 | 11.73 | 10.71 | 10.47 | 8.70 | 8.25 | 7.32 | 7.70 | 7.59 | 7.12 | 7.53 | 6.92 | 1.40 | 1.31 | 1.90 |
ROA % |
4.41 | 3.89 | 3.17 | 4.31 | 4.01 | 4.17 | 3.39 | 4.16 | 4.22 | 4.68 | 3.32 | 4.15 | 4.63 | 4.72 | 3.37 | 4.95 | 4.12 | 5.41 | 4.16 | 6.10 | 6.40 | 6.45 | 5.89 | 6.23 | 6.07 | 5.64 | 6.21 | 5.17 | 5.04 | 4.96 | 4.73 | 3.53 | 3.32 | 3.22 | 3.05 | 4.26 | 4.34 | 4.42 | 5.13 | 5.41 | 5.42 | 5.28 | 4.69 | 4.31 | 4.04 | 3.97 | 3.68 | 3.84 | 3.64 | 3.34 | 3.28 | 2.73 | 2.58 | 2.29 | 2.40 | 2.35 | 2.20 | 2.32 | 2.11 | 0.43 | 0.40 | 0.58 |
Current Ratio |
1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.3 | 1.4 | - | 1.4 | 1.4 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 |
All numbers in USD currency
Multiples are an important financial analysis tool for the company AMERISAFE, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Bermuda
USA
Cayman-islands
Jordan
Canada
Russia
Niderland
